Abstract
Objective: Pancreatic resection may be required in the treatment of patients with pathologies of the pancreas. Total pancreatectomy is a major surgical procedure with serious risk of mortality and morbidity, and patient selection is important for prognosis. The endocrine and exocrine pancreatic insufficiency that develops in patients after total pancreatectomy can lead to a serious decrease in the quality of life of the patients due to pain, diarrhea, vomiting etc. Our aim was to evaluate the effect of total pancreatectomy with spleen preservation as well as splenectomy on the quality of life of the patients.
Material and Methods: In our study, we retrospectively analyzed the data of patients diagnosed with pancreatic cancer, intrapapillary mucinous neoplasia, pancreatic neuroendocrine tumors, and chronic pancreatitis undergoing from partial to total pancreatic resections in our clinic between 12/2017 and 12/2022. Quality of life was compared using the EORTC QLQ-C30 scale.
Results: A total of 47 total pancreatectomy patients, 30 (63.8%) males and 17 (36.2%) females, were included in the study. Mean age of the patients was 61.38 (39-83) years. Five (35.7%) patients underwent perioperative total pancreatectomy because of high risk of pancreatic fistula development due to hard parenchyma and narrow pancreatic duct. Patients had a perioperative blood loss of 500 mL or more, and there was a statistically significant increase in perioperative blood loss compared to patients without vascular resection (p< 0.001). Forty (85.1%) patients used enzyme preparations to replace pancreatic enzymes.
Conclusion: After total pancreatectomy, quality of life of the patients is reduced both by surgical factors and by metabolic factors due to endocrine and exocrine insufficiency in the postoperative period.
Publisher
Turkish Journal of Surgery
Reference41 articles.
1. Leung PS. Physiology of the pancreas. Adv Exp Med Biol 2010; 690: 13- 27. https://doi.org/10.1007/978-90-481-9060-7_2
2. Wilson GC, Sutton JM, Smith MT, Schmulewitz N, Salehi M, Choe KA, et al. Completion pancreatectomy and islet cell autotransplantation as salvage therapy for patients failing previous operative interventions for chronic pancreatitis. Surgery 2015; 158(4): 872-8; discussion 879- 80. https://doi.org/10.1016/j.surg.2015.04.045
3. Yamaguchi K, Konomi H, Kobayashi K, Ogura Y, Sonoda Y, Kawamoto M, et al. Total pancreatectomy for intraductal papillary-mucinous tumor of the pancreas: Reappraisal of total pancreatectomy. Hepatogastroenterology 2005; 52(65): 1585-90.
4. Johnston WC, Hoen HM, Cassera MA, Newell PH, Hammill CW, Hansen PD, et al. Total pancreatectomy for pancreatic ductal adenocarcinoma: Review of the National Cancer Database. HPB (Oxford) 2016; 18(1): 21-8. https://doi.org/10.1016/j.hpb.2015.07.009
5. Rockey EW. Total pancreatectomy for carcinoma: Case report. Ann Surg 1943; 118(4): 603-11. https://doi.org/10.1097/00000658- 194310000-00008